Exercise of Options & PDMR Dealings

Avingtrans

14/11/2025 08:38

RNS Number : 5931H

Avingtrans PLC

14 November 2025

 

14 November 2025

 

Avingtrans Plc

 

("Avingtrans", the "Company", or the "Group")

 

Exercise of Options & PDMR Dealings

 

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces that on 13 November 2025, the Company was notified of the exercise of 591,614 options over ordinary shares of 5p each in the Company ("Ordinary Shares") by Steve McQuillan, Chief Executive Officer, and Stephen King, Chief Financial Officer, pursuant to the Company's Executive Shared Ownership Plans (the "ExSOP Options").

 

Details of the exercise of ExSOP Options by Steve McQuillan and Stephen King, together with subsequent beneficial holdings of each individual following the transactions, are set out below.

 

PDMR
Role
FY 2019 ExSOP options exercised
FY 2016 ExSOP options exercised
Beneficial interest in Ordinary Shares following the transactions
Resulting percentage holding of enlarged total voting rights held
Steve McQuillan
Chief Executive Officer
77,061
258,877
806,925
2.44%
Stephen King
Chief Financial Officer
68,254
187,422
667,614
2.02%

 

The 591,614 Ordinary Shares are currently held by the Company's Employee Benefit Trust and will be transferred to Steve McQuillan and Stephen King and, as such, no new Ordinary Shares have been issued in connection with the transactions.

 

Therefore, the total number of Ordinary Shares with voting rights in the Company remains at 33,130,422. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Group under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

  

 

Enquiries:

Avingtrans plc
01354 692 391
Roger McDowell, Chairman
Steve McQuillan, Chief Executive Officer
Stephen King, Chief Financial Officer
Singer Capital Markets (Nominated Adviser and Broker)
020 7496 3000
Sara Hale
Alex Bond
Oliver Platts
IFC Advisory (Financial PR)
020 3934 6630
Graham Herring
Tim Metcalfe
Zach Cohen


 

About Avingtrans plc:

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide. 

Business units

Hayward Tyler - Luton, East Kilbride UK, USA, China and India
Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.
Energy Steel, Inc - Rochester Hills, Michigan, USA
Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications; engineering design solutions; product refurbishment; on-site technical support.
Stainless Metalcraft Ltd - Chatteris, UK
Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.
Booth Industries - Bolton, UK
Designs, manufactures, installs and services doors and walls which can be tailored to be: blast and explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above.
Ormandy Group - Bradford, UK
Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products.
Slack & Parr - Kegworth, UK, USA & China
Design, manufacture and servicing of high-precision gear metering pumps, hydraulics flow dividers and industrial pumps.
Composite Products Ltd - Buckingham, UK
Centre for composite technology, parts and assemblies, serving customers in industrial markets.
Adaptix Ltd - Oxford, UK
Adaptix has developed novel 3D X-ray for Orthopaedic and Veterinary applications amongst others. Commercialisation of this system (and others) is on-going.
Magnetica Ltd - Brisbane, Australia
Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units:
Scientific Magnetics - Abingdon, UK
Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments.
Tecmag Inc - Houston, USA
Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
1. Steve McQuillan
2. Stephen King
2
Reason for the notification
a)
Position/status
1. Chief Executive Officer
2. Chief Financial Officer
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Avingtrans PLC
b)
LEI
213800ZZ96CKPI423E86
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of 5p each
Identification code
ISIN: GB0009188797
b)
Nature of the transaction
Exercise of options pursuant to the FY 2019 ExSOP
c)
Price(s) and volume(s)
Price(s)
Volume(s)
1.
520.0p
77,061
2.
520.0p
68,254
d)
Aggregated information
n/a
- Aggregated volume
- Price
e)
Date of the transaction
13 November 2025
f)
Place of the transaction
Off market


 

 

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
1. Steve McQuillan
2. Stephen King
2
Reason for the notification
a)
Position/status
1. Chief Executive Officer
2. Chief Financial Officer
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Avingtrans PLC
b)
LEI
213800ZZ96CKPI423E86
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of 5p each
Identification code
ISIN: GB0009188797
b)
Nature of the transaction
Exercise of options pursuant to the FY 2016 ExSOP
c)
Price(s) and volume(s)
Price(s)
Volume(s)
1.
520.0p
258,877
2.
520.0p
187,422
d)
Aggregated information
n/a
- Aggregated volume
- Price
e)
Date of the transaction
13 November 2025
f)
Place of the transaction
Off market

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHBIBPTMTJBMAA